TransMedics Group Inc (TMDX)

Exchange
NASDAQ
Symbol
TMDX
Sector
Life Sciences
Industry
Electromedical & Electrotherapeutic Apparatus
Description
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
Country
USA

Stock price

At close: July 17, 2025

  • Open
    113.20
  • High
    115.37
  • Low
    112.26
  • Close
    112.52
  • Volume
    568,313

Financial ratios

Dec 31, 2024